Introduction to P21 5mg (P021)

P21 5mg (also known as P021) is a novel, synthetic peptide derivative developed as a stable, blood-brain barrier-permeable mimic of Ciliary Neurotrophic Factor (CNTF). It is a modified tetrapeptide sequence (DGGL) appended to an adamantyl moiety at the C-terminus to enhance lipophilicity and structural stability against plasma peptidases. Unlike native CNTF, which has poor pharmacokinetics and a tendency to induce neutralizing antibodies, P21 acts as an optimized neurotrophic strategy. At USA PEPTIDE SCIENCES, we supply this advanced neurogenic compound in a 5mg lyophilized format, providing neuroscience laboratories with a highly pure and stable reagent to investigate cell-autonomous neurogenesis, dentate gyrus restoration, and cellular repair pathways.

Research Overview: Neurogenesis and Neurotrophic Factor Kinetics

The primary scientific value of P21 5mg centers on its capacity to enhance endogenous neurotrophic cascades. Rather than binding directly to the low-affinity CNTF receptor alpha ($\text{CNTFR}\alpha$), P21 operates as a competitive inhibitor of the enzymes responsible for breaking down endogenous neurotrophic factors. It specifically prevents the neutralization of Brain-Derived Neurotrophic Factor (BDNF) and Neurotrophin-3 (NT-3), effectively upregulating their local tissue concentrations.

Key areas of active scientific investigation utilizing P21 include:

• Hippocampal Neurogenesis Dynamics: Modeling the proliferation, maturation, and functional integration of neural stem/progenitor cells (NPCs) into the subgranular zone of the dentate gyrus.

• Synaptic Plasticity and LTP Acceleration: Investigating alterations in long-term potentiation (LTP) thresholds, synaptic density, and dendritic spine configuration in cellular models of cognitive decline.

• Tau and Amyloid Modulation Cascades: Analyzing downstream transcriptomic responses to observe if upregulated neurotrophic signaling mitigates the accumulation of hyperphosphorylated tau proteins or amyloid-beta plaques in vitro.

• Enzymatic Degradation Protection: Quantifying the peptide’s structural resistance to proteolytic enzymes and its efficiency in augmenting native BDNF signaling pathways.

Quality Standards & Analytical Testing

At USA PEPTIDE SCIENCES, maintaining absolute data integrity and chemical fidelity is the foundation of our manufacturing operations. Every batch of P21 5mg is synthesized under rigid quality control standards to eliminate experimental variables. We utilize High-Performance Liquid Chromatography (HPLC) to verify an absolute chemical purity profile of 99% or greater. Additionally, Mass Spectrometry (MS) is conducted to validate the exact amino acid sequence identity and confirm the secure attachment of the lipophilic adamantyl modification. A batch-specific Certificate of Analysis (COA) is issued with every order to secure total transparency for your laboratory data.

Storage and Handling Requirements

To safeguard the precise molecular structure and peptide bonds of P21 5mg, the vacuum-sealed, lyophilized powder must be stored long-term in a freezer environment at -20°C. Prior to introducing the compound into your laboratory workflow, reconstitution must be carried out using an appropriate sterile, non-pyrogenic, or bacteriostatic diluent. Once transitioned into a liquid state, the peptide is highly sensitive to thermal breakdown; it must be kept under constant refrigeration at 2°C to 8°C. Researchers must dissolve the compound via a slow, gentle swirling motion, avoiding any aggressive mechanical agitation or shaking.

Research Use Disclaimer

The compounds distributed by USA PEPTIDE SCIENCES, including P21 5mg (P021), are designated strictly for laboratory research purposes only. Under no circumstances are these products approved or intended for human or veterinary consumption, direct clinical diagnostics, or therapeutic drug administration. All handling, measuring, and experimental evaluation must be conducted exclusively by qualified scientific professionals within a certified and monitored research facility.